Catecholaminergic Polymorphic Ventricular Tachycardia

1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Cardurion Pharmaceuticals
1 program
1
CRD-4730Phase 21 trial
Active Trials
NCT06658899RecruitingEst. Apr 2027

Trial Timeline

Clinical trial activity over time

2025
2026
2027
Cardurion PharmaceuticalsCRD-4730

Clinical Trials (1)

NCT06658899Cardurion PharmaceuticalsCRD-4730

A Phase 2 Study of CRD-4730 in CPVT

Start: Dec 2025Est. completion: Apr 2027
Phase 2Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space